A subsidiary has been "blacklisted" by Shenzhen for one year. Jointown Pharmaceutical Group claims to be "in the process of defending". The industry believes that the intensity of procurement supervision is continuously increasing.

Recently, Jointown Pharmaceutical Group's subsidiary, Jointown Medical Device, was fined and banned from participating in Shenzhen procurement for one year due to providing false information in a tender at a hospital in Shenzhen. Jointown Pharmaceutical Group responded to a reporter from Caijing.com.cn, stating that this incident is a pending matter, and they have organized appeal materials and are currently undergoing administrative reconsideration. This year, several listed companies have been fined for violations in the bidding and procurement process, leading industry insiders to suggest that companies should pay more attention to compliance with details during the bidding process.

cls.cnSep 6 17:24

Hong Kong stock opportunities tracking | The Ministry of Industry and Information Technology will implement large-scale equipment digitization transformation and update; baic motor plans to subscribe to the new energy fund shares with 2 billion yuan.

HKEX will launch a weekly stock options series, trading will begin on November 4th; State Council: Expand the cross-border use of the RMB in the field of service trade; State Tobacco Monopoly Administration issued a notice on the revision and issuance of the management regulations for electronic cigarette trade.

Futu NewsSep 3 08:07

Head accounting firms have also been heavily penalized, with penalties directly related to ten violations. Currently, there are 53 IPO projects under review.

luoxin pharmaceuticals group stock's financial report audit has ten major professional issues, Tianjian Accounting Firm has been warned; Tianjian Accounting Firm is currently conducting audits for a total of 86 projects, including 53 IPO projects under review; 34 accounting firms have been fined this year, and the key is to strengthen the responsibility of the 'gatekeepers'.

cls.cnAug 30 20:24

Zhejiang Jolly Pharmaceutical: The regions that won the centralized procurement bids have basically achieved volume-based pricing and will develop 10 varieties of Wuling series.

①The company has seen both gains and losses in centralized procurement, for example, sales in centralized procurement areas have increased significantly compared to non-centralized procurement areas, but the company once lost the bid in the procurement of Bacillus Subtilis; ②Due to the reduction of sales expenses and other reasons, the net income of the company in the areas where it won the bid in centralized procurement has actually increased; ③Currently, the company's production capacity utilization rate of Trametes versicolor powder is relatively high and expansion projects for the second phase are underway, with future considerations for planning new production capacity.

cls.cnAug 27 16:47

Lepu Medical Technology's performance continued to decline in the first half of the year. It is expected that the revenue of the formulated business will further decrease. | Interpretations

① lepu medical technology once again submitted a half-year report with a decline in performance, and the revenue of the company's three major business sectors decreased year-on-year. ② Due to reasons such as the aging of product pipelines, lepu medical technology determines that the revenue of the formulation business sector may decrease to around 1.5 billion-1.6 billion yuan. ③ The company conducted self-inspection and rectification in response to the issues and requirements raised in the administrative supervision and regulation measures decision issued by the Beijing Securities Regulatory Bureau.

cls.cnAug 23 23:56

High inventory coupled with industry pressure, Chongqing Taiji Industry's H1 revenue and net profit both declined. | Interpretation of financial statements.

In the first half of this year, chongqing taiji industry's net profit was 0.495 billion yuan, a year-on-year decrease of 12.51%; The company stated that the poor performance in the first half of the year was mainly due to the high base of the same period last year and the high social inventory of some products.

cls.cnAug 22 23:19